Up next

Autoplay

RADIANT-3 Trial: Everolimus in Pancreatic Neuroendocrine Tumors

0 Views • 07/08/23
Share
Embed
administrator
administrator
Subscribers
0

Jonathan Strosberg, MD, Diane Reidy-Lagunes, MD, MS, and Rodney F. Pommier, MD, discuss results from the phase III RADIANT-3 trial that explored everolimus in patients with pancreatic neuroendocrine tumors.

For more from this discussion, visit http://www.onclive.com/peer-ex....change/pancreatic-ne

Show more
0 Comments sort Sort By
Facebook Comments

Up next

Autoplay